China Pharma Holdings (CPHI) Reports In-Line Q2 EPS
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/8/2026
- S&P 500, Nasdaq end lower as crude prices jump, chip stocks weigh
- Oil rises 4% on revived Middle East worries, Hurricane Isaias supply disruption
- Chipotle, Starbucks shares volatile after report of potential takeover
- Why Citi says the Fed could be setting up for a dovish surprise
- Alphabet shares rise as Google pushes Gemini deeper into enterprise AI
Tweet
Share
E-mailGet Alerts CPHI Hot Sheet
Price: $0.96 +12.94%
Financial Fact:
Interest expense: -213.74K
Today's EPS Names:
PKE, BYRN, HELE, More
Financial Fact:
Interest expense: -213.74K
Today's EPS Names:
PKE, BYRN, HELE, More
Join SI Premium – FREE
China Pharma Holdings (NYSE: CPHI) reported Q2 EPS of $0.11, in-line with the analyst estimate of $0.11. Revenue for the quarter came in at $19.6 million versus the consensus estimate of $19.46 million.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Helen of Troy (HELE) Tops Q2 EPS by 28c, Misses on Revenue; Offers FY27 Guidance
- Byrna Technologies Inc. (BYRN) Misses Q3 EPS by 9c
- Applied Digital (APLD) Tops Q1 EPS by 26c, Beats on Revenue
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
